Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Any Cancer With Multiple Bone Metastases

Interventions

DEVICE

GammaKnife®

DEVICE

18F-2-fluoro-2-deoxy-D-glucose - positron emission tomography (FDG-PET)

DEVICE

MRI

Trial Locations (1)

RECRUITING

Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02637479 - Treatment of Opioid-refractory Pain (WHO Level III) by Pituitary Radiosurgery | Biotech Hunter | Biotech Hunter